The HPOs will receive $13.8 million to enroll people interested in the All of Us program, gather participant health information, and help retain participants.
This story has been updated from a version published Aug. 15 to reflect the fact that Iverson Genetics has not yet selected a testing partner for the WARFARIN trial.
Morehouse School of Medicine will use the NIH funding and work with several partners to start a minority database focused first on hypertension and personalized medicine.
